Evidence map›Paper›PMID 37845134›Full record

ArticleTrends in microbiology2024

Cellular rejuvenation to combat HIV-1-related neurocognitive impairment.

Philipp N Ostermann, Teresa H Evering

Abstract read
In one paragraph

Article in Trends in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Philipp N OstermannDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, 10065 New York, NY, USA. Electronic address: pno4001@med.cornell.edu.
Teresa H EveringDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, 10065 New York, NY, USA.

Funding

A Precision Medicine Approach to Investigating the Molecular Impact of Age and Neurocognitive Impairment in People Living with HIV (PLWH)R21NS126094 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI EVERING, TERESA · 2021 to 2021
$557k
Leveraging Directly Reprogrammed Human Neurons to Investigate the Molecular Impact of Age and Distinct Antiretroviral Therapies in Individuals Living with HIV-1R21AG071433 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI EVERING, TERESA · 2021 to 2022
$489k
NIA NIH HHS R21 AG071433NINDS NIH HHS R21 NS126094
6 · The paper itself

Abstract

HIV-1-related neurocognitive impairment affects a significant proportion of people living with HIV, and accelerated brain aging has been implicated in its pathogenesis. This forum explores the application of cellular rejuvenation strategies to target molecular mechanisms of brain aging, promote neuronal health, and combat cognitive decline.

Indexed as

HIV-1HIV InfectionsAgingBrainHumansRejuvenationaccelerated agingcellular rejuvenationHIVneurocognitive declineneurodegenerative diseasesenescence

Identifiers

PMID37845134
PMCPMC10843288

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.